Cargando…

Hypersensitivity Myocarditis after COVID-19 mRNA Vaccination

Background: Myocarditis, even in a severe and lethal form, may occur after COVID-19 mRNA (BNT162b2) vaccination. However, its pathway, morphomolecular characterization and treatment are still unknown. Methods: Routine hematochemical screening, ECG, Holter monitoring, 2D echocardiogram cardiac magnet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frustaci, Andrea, Verardo, Romina, Galea, Nicola, Lavalle, Carlo, Bagnato, Giulia, Scialla, Rossella, Chimenti, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949349/ https://www.ncbi.nlm.nih.gov/pubmed/35329986 http://dx.doi.org/10.3390/jcm11061660

Ejemplares similares

Pemphigus‐associated cardiomyopathy: report of autoimmune myocarditis and review of literature
por: Frustaci, Andrea, et al.
Publicado: (2021)

Interleukin-17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery following Secukinumab Administration
por: Frustaci, Andrea, et al.
Publicado: (2023)

Inflammation of Conduction Tissue in Patients with Arrhythmic Phenotype of Myocarditis
por: Frustaci, Andrea, et al.
Publicado: (2020)

Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement
por: Frustaci, Andrea, et al.
Publicado: (2022)

Myocardial Aldosterone Receptor and Aquaporin 1 Up-Regulation Is Associated with Cardiomyocyte Remodeling in Human Heart Failure
por: Frustaci, Andrea, et al.
Publicado: (2021)

Biopsy-proven autoimmune myocarditis in HIV-associated dilated cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2014)

Myocarditis and intramural coronary vasculitis in polyarteritis nodosa: an unusual treatable form of heart failure
por: Chimenti, Cristina, et al.
Publicado: (2020)

Immune‐Mediated Myocarditis in Fabry Disease Cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2018)

Myocarditis-associated necrotizing coronary vasculitis: incidence, cause, and outcome
por: Frustaci, Andrea, et al.
Publicado: (2020)

Infarct‐like myocarditis with coronary vasculitis and aneurysm formation caused by Epstein–Barr virus infection
por: Chimenti, Cristina, et al.
Publicado: (2020)

Remarks on Myocarditis Associated with COVID-19 Infection and Myocarditis Following mRNA COVID-19 Vaccination
por: Frustaci, Andrea
Publicado: (2022)

Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
por: Chimenti, Cristina, et al.
Publicado: (2021)

Removal of cardiac AL amyloid with positive remodelling of cardiomyocytes and of restrictive cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2022)

Circulating Anti-GB3 Antibody as a Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2023)

Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
por: Frustaci, Andrea, et al.
Publicado: (2023)

False‐positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy
por: Chimenti, Cristina, et al.
Publicado: (2021)

Infiltration of Conduction Tissue Is a Major Cause of Electrical Instability in Cardiac Amyloidosis
por: Frustaci, Andrea, et al.
Publicado: (2023)

Prevalence and Clinical Implications of COVID-19 Myocarditis
por: Chimenti, Cristina, et al.
Publicado: (2022)

Novel dilated cardiomyopathy associated to Calreticulin and Myo7A gene mutation in Usher syndrome
por: Frustaci, Andrea, et al.
Publicado: (2021)

Virus-Negative Necrotizing Coronary Vasculitis with Aneurysm Formation in Human SARS-CoV-2 Infection
por: Frustaci, Andrea, et al.
Publicado: (2021)

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination
por: Weintraub, Eric S., et al.
Publicado: (2022)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 mRNA Vaccine and Myocarditis
por: Singh, Balraj, et al.
Publicado: (2021)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series
por: del Nonno, Franca, et al.
Publicado: (2020)

Myocarditis Associated with mRNA COVID-19 Vaccination
por: Starekova, Jitka, et al.
Publicado: (2021)

Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021)

Myocarditis following COVID-19 mRNA vaccination
por: Parmar, Kanak, et al.
Publicado: (2021)

COVID-19 mRNA Vaccine-Associated Myocarditis
por: Kyaw, Htin, et al.
Publicado: (2022)

Myocarditis following COVID-19 mRNA vaccination
por: Abu Mouch, Saif, et al.
Publicado: (2021)

COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-phosphate Receptor Expression
por: Frustaci, Andrea, et al.
Publicado: (2022)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
por: Das, Karuna M., et al.
Publicado: (2022)

New Insights in Human Myocarditis
por: Frustaci, Andrea
Publicado: (2022)

Receipt of mRNA Vaccine against Covid-19 and Myocarditis
por: Caforio, Alida L.P.
Publicado: (2021)

PRAC updates risk of myocarditis and pericarditis with mRNA vaccines
Publicado: (2021)

Myocarditis rare after COVID-19 mRNA vaccination
Publicado: (2021)

COVID-19 mRNA vaccination in patients with previous myocarditis
por: Pieroni, Maurizio, et al.
Publicado: (2022)

Myocarditis after COVID‐19 mRNA vaccination in Australia
por: Varma, Suraj K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djduunm6n48mvo25f73vldchjs